Luca Cantini

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Ejection Fraction

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Exploration of targeted anti-tumor therapy

Journal of clinical medicine

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Valeria Cognigni, Federica Pecci, Alessio Lupi, Giada Pinterpe, Chiara De Filippis, Cristiano Felicetti, Luca Cantini, Rossana Berardi
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives. Cancers 14 (19) (2022)
Mariangela Torniai, Veronica Agostinelli, Luca Cantini, Carolina Liguori, Francesca Morgese, Silvia Rinaldi, Laura Scortichini, Rossana Berardi
Management of lung cancer patients during COVID-19 pandemic: dos, don'ts and don't knows. Exploration of targeted anti-tumor therapy 3 (3) (2022)
Luca Cantini, Federica Pecci, Filippo Merloni, Andrea Lanese, Edoardo Lenci, Francesco Paoloni, Joachim G J V Aerts, Rossana Berardi
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC. Exploration of targeted anti-tumor therapy 2 (1) (2021)
Alessandro Bittoni, Riccardo Giampieri, Federica Pecci, Giada Pinterpe, Alessandra Mandolesi, Michela Del Prete, Antonio Zizzi, Sonia Crocetti, Carolina Liguori, Giulia Mentrasti, Luca Cantini, Chiara Pellei, Renato Bisonni, Marina Scarpelli, Rossana Berardi
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Current oncology (Toronto, Ont.) 28 (5) (2021)
Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi, Linda Nicolardi, Andrea Caglio, Sophie Aerts, Alessio Cortellini, Corrado Ficorella, Rita Chiari, Massimo Di Maio, Anne-Marie C Dingemans, Joachim G J V Aerts, Rossana Berardi
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. Journal of clinical medicine 10 (5) (2021)
Luca Cantini, Lucia Bastianelli, Alessio Lupi, Giada Pinterpe, Federica Pecci, Giovanni Belletti, Rosa Stoico, Francesca Vitarelli, Marco Moretti, Nicoletta Onori, Riccardo Giampieri, Marco Bruno Luigi Rocchi, Rossana Berardi
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. Journal of clinical medicine 10 (7) (2021)
Edoardo Lenci, Giulia Marcantognini, Valeria Cognigni, Alessio Lupi, Silvia Rinaldi, Luca Cantini, Ilaria Fiordoliva, Anna Lisa Carloni, Marco Rocchi, Lina Zuccatosta, Stefano Gasparini, Rossana Berardi
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis. Exploration of targeted anti-tumor therapy 2 (3) (2021)